Literature DB >> 9573274

Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.

J L Gerton1, S Ohgi, M Olsen, J DeRisi, P O Brown.   

Abstract

The phylogenetically conserved catalytic core domain of human immunodeficiency virus type 1 (HIV-1) integrase contains elements necessary for specific recognition of viral and target DNA features. In order to identify specific amino acids that determine substrate specificity, we mutagenized phylogenetically conserved residues that were located in close proximity to the active-site residues in the crystal structure of the isolated catalytic core domain of HIV-1 integrase. Residues composing the phylogenetically conserved DD(35)E active-site motif were also mutagenized. Purified mutant proteins were evaluated for their ability to recognize the phylogenetically conserved CA/TG base pairs near the viral DNA ends and the unpaired dinucleotide at the 5' end of the viral DNA, using disintegration substrates. Our findings suggest that specificity for the conserved A/T base pair depends on the active-site residue E152. The phenotype of IN(Q148L) suggested that Q148 may be involved in interactions with the 5' dinucleotide of the viral DNA end. The activities of some of the proteins with mutations in residues in close proximity to the active-site aspartic and glutamic acids were salt sensitive, suggesting that these mutations disrupted interactions with DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573274      PMCID: PMC110067          DOI: 10.1128/JVI.72.6.5046-5055.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

4.  Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.

Authors:  C J Burke; G Sanyal; M W Bruner; J A Ryan; R L LaFemina; H L Robbins; A S Zeft; C R Middaugh; M G Cordingley
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

5.  DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein.

Authors:  F M van den Ent; C Vink; R H Plasterk
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Characterization of recombinant murine leukemia virus integrase.

Authors:  I Dotan; B P Scottoline; T S Heuer; P O Brown
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Substrate specificity of recombinant human immunodeficiency virus integrase protein.

Authors:  R L LaFemina; P L Callahan; M G Cordingley
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.

Authors:  M Wiskerchen; M A Muesing
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  32 in total

1.  Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.

Authors:  K Gao; S L Butler; F Bushman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Authors:  J Y Wang; H Ling; W Yang; R Craigie
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.

Authors:  Matthew C Lee; Jinxia Deng; James M Briggs; Yong Duan
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

4.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.

Authors:  Ira B Dicker; Brian Terry; Zeyu Lin; Zhufang Li; Sagarika Bollini; Himadri K Samanta; Volodymyr Gali; Michael A Walker; Mark R Krystal
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

6.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

7.  Integration specificity of LTR-retrotransposons and retroviruses in the Drosophila melanogaster genome.

Authors:  L N Nefedova; M M Mannanova; A I Kim
Journal:  Virus Genes       Date:  2011-01-08       Impact factor: 2.332

8.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

9.  Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness.

Authors:  Michael E Abram; Rebecca M Hluhanich; Derrick D Goodman; Kristen N Andreatta; Nicolas A Margot; Linda Ye; Anita Niedziela-Majka; Tiffany L Barnes; Nikolai Novikov; Xiaowu Chen; Evguenia S Svarovskaia; Damian J McColl; Kirsten L White; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

10.  Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.

Authors:  Zeina Hobaika; Loussine Zargarian; Yves Boulard; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.